Morgan Stanley’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $293M | Sell |
|
|||||
|
2025
Q2 | $489M | Sell |
|
|||||
|
2025
Q1 | $450M | Sell |
|
|||||
|
2024
Q4 | $537M | Buy |
|
|||||
|
2024
Q3 | $352M | Sell |
|
|||||
|
2024
Q2 | $638M | Buy |
|
|||||
|
2024
Q1 | $698M | Sell |
|
|||||
|
2023
Q4 | $1.27B | Buy |
|
|||||
|
2023
Q3 | $413M | Buy |
|
|||||
|
2023
Q2 | $537M | Buy |
|
|||||
|
2023
Q1 | $485M | Sell |
|
|||||
|
2022
Q4 | $489M | Sell |
|
|||||
|
2022
Q3 | $351M | Sell |
|
|||||
|
2022
Q2 | $327M | Buy |
|
|||||
|
2022
Q1 | $358M | Sell |
|
|||||
|
2021
Q4 | $459M | Sell |
|
|||||
|
2021
Q3 | $681M | Sell |
|
|||||
|
2021
Q2 | $918M | Sell |
|
|||||
|
2021
Q1 | $861M | Sell |
|
|||||
|
2020
Q4 | $1.15B | Sell |
|
|||||
|
2020
Q3 | $1.7B | Buy |
|
|||||
|
2020
Q2 | $1.48B | Sell |
|
|||||
|
2020
Q1 | $1.09B | Sell |
|
|||||
|
2019
Q4 | $913M | Buy |
|
|||||
|
2019
Q3 | $467M | Buy |
|
|||||
|
2019
Q2 | $459M | Sell |
|
|||||
|
2019
Q1 | $567M | Sell |
|
|||||
|
2018
Q4 | $625M | Sell |
|
|||||
|
2018
Q3 | $784M | Buy |
|
|||||
|
2018
Q2 | $478M | Buy |
|
|||||
|
2018
Q1 | $321M | Buy |
|
|||||
|
2017
Q4 | $228M | Buy |
|
|||||
|
2017
Q3 | $126M | Buy |
|
|||||
|
2017
Q2 | $180M | Buy |
|
|||||
|
2017
Q1 | $177M | Buy |
|
|||||
|
2016
Q4 | $106M | Buy |
|
|||||
|
2016
Q3 | $66.8M | Sell |
|
|||||
|
2016
Q2 | $67M | Sell |
|
|||||
|
2016
Q1 | $76.6M | Sell |
|
|||||
|
2015
Q4 | $104M | Buy |
|
|||||
|
2015
Q3 | $108M | Buy |
|
|||||
|
2015
Q2 | $15.8M | Buy |
|
|||||
|
2015
Q1 | $8.7M | Buy |
|
|||||
|
2014
Q4 | $5.66M | Sell |
|
|||||
|
2014
Q3 | $6.15M | Buy |
|
|||||
|
2014
Q2 | $3.87M | Sell |
|
|||||
|
2014
Q1 | $4.61M | Buy |
|
|||||
|
2013
Q4 | $3.87M | Buy |
|
|||||
|
2013
Q3 | $2.25M | Buy |
|
|||||
|
2013
Q2 | $1.62M | Buy |
|